Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05331599

Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-Life Depression

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
210 (estimated)
Sponsor
University of Illinois at Chicago · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

Late-life depression (LLD) is associated with disability, increased risk for cognitive decline and dementia, elevated suicide risk, and greater all-cause mortality. These outcomes are related to depression being a recurrent disorder, with repeated episodes over a patient's lifetime. Recurrence rates (defined as including both relapse and recurrence) are high in LLD. The goals of this study are to identify neurobiological factors that predict recurrence risk, and examine how cognitive performance changes are both influenced by these neurobiological factors and also predict recurrence risk.

Conditions

Timeline

Start date
2020-06-01
Primary completion
2025-05-15
Completion
2026-01-15
First posted
2022-04-15
Last updated
2025-09-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05331599. Inclusion in this directory is not an endorsement.

Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-Life Depression (NCT05331599) · Clinical Trials Directory